What are the potential risks to race-specific drug approvals


Problem: Is it appropriate for the FDA to approve drugs for race-specific indications, as it did with BiDil?  What are the potential risks to race-specific drug approvals?  What might the FDA (or other entities) do to mitigate these risks?

Request for Solution File

Ask an Expert for Answer!!
Other Subject: What are the potential risks to race-specific drug approvals
Reference No:- TGS03317941

Expected delivery within 24 Hours